Impress employers and recruiters.
Choose from hundreds of resume examples.

Target Resume Now

About the Role

The Senior Director, National and Strategic Accounts will be a key member of the Market Access leadership team, responsible for developing the Market Access Payer strategic plan and vision for business opportunities in national and regional markets to support the launch of palazestrant and future therapies. This role requires strategic and tactical expertise in market access, payer coverage, and contracting, with a deep understanding of the oncology business and provider networks. The individual will analyze market dynamics, including coverage, reimbursement, payer policies, formulary listings, competitive landscape, pricing, and contracting strategies, to ensure patient access.

Responsibilities

Leads and inspires a team of national account directors focused on achieving Market Access objectives.
Collaborates with commercial leadership and executive management to develop and refine the company’s payer and organized customer access strategy.
Provides input on product and service offerings, pricing, and contracting.
Informs the organization of market trends, insights, risks, and opportunities.
Recruits, trains, and manages a team of Payer/GPO/Organized customer account professionals.
Partners with Market Access Payer Marketing, Trade and Channel management, Patient Support Services, and Marketing to develop customer pull-through strategies.
Leverages existing relationships at strategic payer and provider accounts to communicate the value proposition of launch products.
Acts as the key relationship owner for Olema Oncology accounts.
Develops customer roadmaps, segmentation, and account plans for all targeted accounts.
Drives contracted customer pull-through and contract compliance.
Builds and maintains strong client relationships and drives key initiatives.
Collaborates with field teams to identify and mitigate access barriers.
Leads payer discussions to secure long-term partnerships.
Manages budget and vendors for timely and fiscally responsible project execution.
Collaborates with internal and external partners to create effective tools and content for payers and Health Care Decision Maker stakeholders.

Requirements

15+ years of bio/pharmaceutical experience with a key understanding of current US pharmaceutical payer models.
10+ years of direct US Payer and/or Provider Account management experience (NAM, RAM, KAM).
5+ years of people management experience.
Previous experience working in the pharmaceutical or biotech industry, with a strong preference for Oncology.
Successful product launch experience in the US, with a preference for Oncology drug launch.
Strong knowledge of the oncology oral therapies marketplace.
Experience working with key decision makers within Organized accounts and institutions to pull through access.
Seasoned National Accounts leader with Oncology experience preferred.
In-depth knowledge of pharmaceutical manufacturer compliance requirements, patient confidentiality (HIPAA regulations), product reimbursement, and product access.
Knowledge and experience in Medicare Part A-D, Medicaid, VA/DoD and commercial payer policies, reimbursement process, health policy, and areas of coverage and payment.
Experience partnering with Payers and IDNs to establish patient and HCP pull-through support programs.
Demonstrated experience in process development for coordination with HUB, co-pay, and other patient service providers.
Demonstrated skills in business planning and payer strategy development with strong problem-solving skills.
Demonstrated negotiation skills and financial acumen required to manage complex customer engagements and contractual agreements.
Strong communicator with the ability to influence others.
Experience with Commercial Brand Planning process, able to translate brand disease state and business drivers into payer programs.
Ability to translate and compile data into comprehensive and functional reports.
Strong leadership and teamwork skills with demonstrated skills working cross-functionally to gain alignment and improve business performance.
Highly organized and detail-oriented.
Excellent written and oral communication skills.

Skills

Market Access
Payer Coverage
Contracting
Oncology Business
Provider Networks
Coverage Analysis
Reimbursement Analysis
Payer Policy Analysis
Formulary Listing Analysis
Competitive Landscape Analysis
Pricing Strategy
Contracting Strategy
Key Opinion Leader Engagement
Public Policy
Engagement Strategy
Tactical Plan Development
National Account Management
Regional Account Management
Key Account Management
People Management
Product Launch
Oral Therapies Marketplace
Organized Accounts
Institutions
Compliance
HIPAA
Medicare Part A-D
Medicaid
VA/DoD
Commercial Payer Policies
Reimbursement Process
Health Policy
Patient Support Programs
HCP Support Programs
HUB Services Coordination
Co-pay Services Coordination
Business Planning
Payer Strategy Development
Problem-Solving
Negotiation
Financial Acumen
Communication
Influence
Commercial Brand Planning
Data Translation
Report Compilation
Leadership
Teamwork
Cross-functional Collaboration
Organization
Detail-Orientation

Location

Remote

Work Type

Remote
Full-time

Experience Level

15+ years bio/pharmaceutical experience
10+ years US Payer/Provider Account Management
5+ years people management
Senior Director

Education Level

Bachelor's Degree required
Degree in health sciences or business/marketing preferred
MBA, Pharm D or other advanced degree is a plus

Salary/Compensations

$250,000 - $275,000 annually

Benefits

Equity
Bonus
Competitive compensation and benefits package
Open, flexible, and friendly work environment
Platform to develop long-term careers
Summary of Benefits available

About the Company

Olema Oncology is a clinical-stage biopharmaceutical company committed to transforming the standard of care and improving outcomes for patients living with breast cancer and beyond.
Our lead product candidate, palazestrant, is a novel, orally available complete estrogen receptor antagonist (CERAN) and selective estrogen receptor degrader (SERD) currently in two pivotal Phase 3 clinical trials.
Our follow-on product candidate, OP-3136, is a potent KAT6 inhibitor with the potential to generate further value and meaningfully impact the metastatic breast cancer treatment landscape.
We possess a deep commitment to our shared purpose, the sustained pursuit of excellence, cultivating the courage required to advance our programs, drive to succeed, and a collective capacity for adaptability through learning, growth, and evolution.
Team Olema is made up of nimble self-starters who bring consistency in their quest for the extraordinary every single day.

Equal Opportunity

We provide equal opportunity to all employees and applicants for employment and believe that great ideas and discoveries come from a mix of expertise, background, and experience.
Olema is building a culture where the value of difference is celebrated.